Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
about
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction StudyEmerging biomarkers in heart failure and cardiac cachexiaSecreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential.Wnt Signaling in Cardiac Disease.Improving prediction of cardiovascular complications of cancer therapy: what does the future hold?Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction.Insulin-Like Growth Factor 1 in the Cardiovascular System.MicroRNAs Associated With Reverse Left Ventricular Remodeling in Humans Identify Pathways of Heart Failure Progression.Wnt Signaling in Cardiac Remodeling and Heart Failure.Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action.Obesity-mediated regulation of cardiac protein acetylation: parallel analysis of total and acetylated proteins via TMT-tagged mass spectrometry
P2860
Q31036336-37BA4837-4FFE-44AC-9A60-BA9ED455E064Q34836097-B79BBC3A-59D2-4AAF-BFED-4B21D848127CQ35750462-B70E9C81-D455-422D-947A-27D1D4E050E7Q36171125-56759177-2133-4B3B-A19E-38FC0E98DAB7Q38540889-3CFB1264-9038-4F64-B28E-5ED64E39ADA0Q38542451-9DB28874-BC31-40F8-A77E-178D1AA90224Q38978030-0AAA287B-EAB0-4431-839F-7252320CD38BQ41245359-7BCF6E21-6DDC-4FCF-A5B9-3793AFCDC6D3Q42547157-18934081-410F-4D82-B6E5-0D81104F9C8CQ42679350-7E3BE4D3-CDB1-41AE-98E3-60A3018FC0A2Q47102600-8EB1AEFD-A854-46E5-91AC-427E97FFDAA5Q47222500-0E45E13E-2AF5-41BC-9B39-F2B17F331446Q50036977-60A4C4B3-F855-4D9A-B1CD-7594316A2156Q52815224-AE11E362-ECBC-4BBE-A6A0-35A5EF067D7FQ53502512-1C25284D-9A0C-444F-B810-80201F35F170Q58760378-A528DA52-8FBC-44A9-8809-90B52F470970
P2860
Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Measurement of novel biomarker ...... d left ventricular remodeling.
@en
Measurement of novel biomarker ...... d left ventricular remodeling.
@nl
type
label
Measurement of novel biomarker ...... d left ventricular remodeling.
@en
Measurement of novel biomarker ...... d left ventricular remodeling.
@nl
prefLabel
Measurement of novel biomarker ...... d left ventricular remodeling.
@en
Measurement of novel biomarker ...... d left ventricular remodeling.
@nl
P2093
P2860
P1476
Measurement of novel biomarker ...... d left ventricular remodeling.
@en
P2093
Aaron L Baggish
Anju Bhardwaj
Arianna Belcher
Hanna K Gaggin
Jackie Szymonifka
Rory B Weiner
Shweta R Motiwala
P2860
P2888
P304
P356
10.1007/S12265-013-9522-8
P407
P577
2013-12-06T00:00:00Z
P6179
1011702389